홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

HCID 23312524, 화합물 → HCID 23312521, 화합물

HRID 325516
노트
인쇄 미리보기

반응식

HRID 325516 반응식
NC1C(NCCSCC2C=C(CN(C)C)SC=2)=NS(=O)N=1.[NH2:22][C:23]1[C:27]([NH:28][CH2:29][CH2:30][S:31][CH2:32][C:33]2[S:34][C:35]([CH2:39][N:40]([CH3:42])[CH3:41])=[C:36]([CH3:38])[CH:37]=2)=[N:26][S:25](=O)[N:24]=1>>[NH2:22][C:23]1[C:27]([NH:28][CH2:29][CH2:30][S:31][CH2:32][C:33]2[S:34][C:35]([CH2:39][N:40]([CH3:41])[CH3:42])=[C:36]([CH3:38])[CH:37]=2)=[N:26][S:25][N:24]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 23312524HCID 23312524, 화합물HCID 23312529HCID 23312529, 화합물

생성물 1

HCID 23312521HCID 23312521, 화합물

실험 절차

The general procedure of Example 5 is repeated except that the 3-amino-4-{2-[(5-dimethylaminomethyl-3-thienyl)methylthio]ethylamino}-1,2,5-thiadiazole 1-oxide utilized therein is replaced by an equimolar amount of 3-amino-4-{2-[(5-dimethylaminomethyl-4-methyl-2-thienyl)methylthio]ethylamino}-1,2,5-thiadiazole 1-oxide [prepared according to the general procedure described in U.S. Pat. No. 4,374,248], and the title compound is thereby produced.

후처리

  1. customprepared

출처 및 근거

ORD 기록
ord-01957a376c9e45258e2f908a945361ab
출처 데이터셋
uspto-grants-1984_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04440933

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트